Stock Analysts’ updated eps estimates for Monday, January 27th:
Apple (NASDAQ:AAPL) had its buy rating reissued by analysts at Rosenblatt Securities. They currently have a $262.00 target price on the stock.
Abbott Laboratories (NYSE:ABT) had its overweight rating reaffirmed by analysts at Barclays PLC. They currently have a $158.00 target price on the stock, up from their previous target price of $149.00.
Amazon.com (NASDAQ:AMZN) had its outperform rating reissued by analysts at Wedbush. They currently have a $280.00 price target on the stock, up from their previous price target of $260.00.
Ares Management (NYSE:ARES) had its overweight rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $224.00 price target on the stock.
American Express (NYSE:AXP) had its outperform rating reiterated by analysts at William Blair.
Aspen Technology (NASDAQ:AZPN) had its neutral rating reissued by analysts at Robert W. Baird. They currently have a $265.00 target price on the stock, down from their previous target price of $275.00.
Bar Harbor Bankshares (NYSEAMERICAN:BHB) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $35.00 price target on the stock, up from their previous price target of $34.00.
Cidara Therapeutics (NASDAQ:CDTX) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald.
Check Point Software Technologies (NASDAQ:CHKP) had its neutral rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $200.00 price target on the stock.
Century Casinos (NASDAQ:CNTY) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $5.00 target price on the stock.
Coursera (NYSE:COUR) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $11.00 target price on the stock.
CSX (NASDAQ:CSX) had its buy rating reissued by analysts at Benchmark Co.. The firm currently has a $38.00 price target on the stock.
Cybin (NYSE:CYBN) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $190.00 target price on the stock.
CyberArk Software (NASDAQ:CYBR) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $415.00 price target on the stock.
Dolby Laboratories (NYSE:DLB) had its outperform rating reissued by analysts at Barrington Research. They currently have a $100.00 target price on the stock.
DoubleVerify (NYSE:DV) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $25.00 target price on the stock.
Eastern Bankshares (NASDAQ:EBC) had its outperform rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $22.00 target price on the stock, up from their previous target price of $21.00.
Esquire Financial (NASDAQ:ESQ) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $85.00 price target on the stock, up from their previous price target of $80.00.
Exelixis (NASDAQ:EXEL) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $40.00 price target on the stock.
Exelixis (NASDAQ:EXEL) had its equal weight rating reissued by analysts at Stephens. Stephens currently has a $29.00 price target on the stock.
First Financial Bancorp. (NASDAQ:FFBC) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $30.00 price target on the stock.
Full House Resorts (NASDAQ:FLL) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $6.00 target price on the stock.
Gannett (NYSE:GCI) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $6.00 price target on the stock.
Genius Sports (NYSE:GENI) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $11.00 price target on the stock.
GH Research (NASDAQ:GHRS) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $40.00 target price on the stock.
Glaukos (NYSE:GKOS) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $180.00 target price on the stock, up from their previous target price of $140.00.
Alphabet (NASDAQ:GOOGL) had its market perform rating reaffirmed by analysts at JMP Securities.
HCA Healthcare (NYSE:HCA) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $405.00 target price on the stock.
H&R Block (NYSE:HRB) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $70.00 target price on the stock.
Harmony Biosciences (NASDAQ:HRMY) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $75.00 target price on the stock.
Heritage Commerce (NASDAQ:HTBK) had its equal weight rating reaffirmed by analysts at Stephens. They currently have a $11.00 price target on the stock.
International Business Machines (NYSE:IBM) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $250.00 price target on the stock.
ImmunityBio (NASDAQ:IBRX) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $30.00 target price on the stock.
Immunocore (NASDAQ:IMCR) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $100.00 target price on the stock.
Inspired Entertainment (NASDAQ:INSE) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $14.00 price target on the stock.
Inter Parfums (NASDAQ:IPAR) had its buy rating reiterated by analysts at BWS Financial. The firm currently has a $172.00 price target on the stock.
Invivyd (NASDAQ:IVVD) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $9.00 price target on the stock.
Lakeland Financial (NASDAQ:LKFN) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. The firm currently has a $74.00 target price on the stock, up from their previous target price of $73.00.
Light & Wonder (NASDAQ:LNW) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $114.00 price target on the stock.
Grand Canyon Education (NASDAQ:LOPE) had its outperform rating reaffirmed by analysts at Barrington Research. The firm currently has a $180.00 target price on the stock.
Meta Platforms (NASDAQ:META) had its underperform rating reaffirmed by analysts at Needham & Company LLC.
Meta Platforms (NASDAQ:META) had its buy rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $811.00 price target on the stock.
Meta Platforms (NASDAQ:META) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $750.00 target price on the stock.
Milestone Pharmaceuticals (NASDAQ:MIST) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $25.00 price target on the stock.
Nexxen International (NASDAQ:NEXN) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $11.00 target price on the stock.
NVIDIA (NASDAQ:NVDA) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $200.00 price target on the stock.
Realty Income (NYSE:O) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $62.00 target price on the stock.
PubMatic (NASDAQ:PUBM) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $20.00 price target on the stock.
RH (NYSE:RH) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $500.00 target price on the stock.
RCI Hospitality (NASDAQ:RICK) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $98.00 target price on the stock.
Cartesian Therapeutics (NASDAQ:RNAC) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $41.00 target price on the stock.
Super Group (NYSE:SGHC) had its buy rating reissued by analysts at Benchmark Co.. The firm currently has a $10.00 target price on the stock.
Sangamo Therapeutics (NASDAQ:SGMO) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $10.00 target price on the stock.
Snap (NYSE:SNAP) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $16.00 price target on the stock.
South Plains Financial (NASDAQ:SPFI) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. The firm currently has a $45.00 price target on the stock, down from their previous price target of $46.00.
Sportradar Group (NASDAQ:SRAD) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $19.00 price target on the stock.
Sarepta Therapeutics (NASDAQ:SRPT) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $202.00 target price on the stock.
Uber Technologies (NYSE:UBER) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $90.00 target price on the stock.
United Bankshares (NASDAQ:UBSI) had its equal weight rating reiterated by analysts at Stephens. The firm currently has a $43.00 price target on the stock.
VICI Properties (NYSE:VICI) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $35.00 price target on the stock.
Voyager Therapeutics (NASDAQ:VYGR) had its buy rating reissued by analysts at HC Wainwright. They currently have a $30.00 price target on the stock.
WD-40 (NASDAQ:WDFC) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $322.00 target price on the stock.
Receive News & Ratings for Apple Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple Inc and related companies with MarketBeat.com's FREE daily email newsletter.